Virax Biolabs Group Limited
Virax Biolabs Group Limited (VRAX) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
vrax · market cap & enterprise value · FMP · as of Jun 9, 2026
Core market cap & key metrics
As of Jun 9, 2026, Virax Biolabs Group Limited (VRAX) has a market cap — also referred to as its net worth or valuation — of $817,156, making it one of the top most valuable companies globally. Market Cap = $0.19 × shares outstanding.
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Virax Biolabs Group Limited (VRAX) has a market cap — also referred to as its net worth or valuation — of $817,156 as of Jun 9, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Virax Biolabs Group Limited reached its all-time high market cap of $0 on —. Comparing the Virax Biolabs Group Limited market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Virax Biolabs Group Limited net worth vs peers and ask how Virax Biolabs Group Limited valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
VRAX market cap · 6 questionsVirax Biolabs Group Limited's net worth — measured as market capitalization — is $817,156 as of Jun 9, 2026. It ranks #0 globally. Market Cap = $$0.19 (price) × shares outstanding.